daridorexant
Selected indexed studies
- Daridorexant for the Treatment of Insomnia. (Health Psychol Res, 2022) [PMID:36045942]
- Comparative efficacy and safety of daridorexant, lemborexant, and suvorexant for insomnia: a systematic review and network meta-analysis. (Transl Psychiatry, 2025) [PMID:40555730]
- Daridorexant. (, 2006) [PMID:35073032]
_Worker-drafted node — pending editorial review._
Connections
daridorexant is a side effect of
Sources
- Daridorexant for the Treatment of Insomnia. (2022) pubmed
- Comparative efficacy and safety of daridorexant, lemborexant, and suvorexant for insomnia: a systematic review and network meta-analysis. (2025) pubmed
- Daridorexant. (2006) pubmed
- Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials. (2022) pubmed
- Daridorexant as a novel pharmacotherapeutic approach in insomnia: a systematic review and meta-analysis. (2023) pubmed
- Daridorexant in Japanese patients with insomnia disorder: A phase 3, randomized, double-blind, placebo-controlled study. (2024) pubmed
- Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder. (2023) pubmed
- Daridorexant. (2012) pubmed
- Daridorexant: First Approval. (2022) pubmed
- Daridorexant for the treatment of insomnia disorder: findings and implications. (2022) pubmed